{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:50:29Z","timestamp":1785703829569,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rceng.2026.502579","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:09:01Z","timestamp":1779980941000},"page":"502579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolic disease associated with hormonal contraceptives. Venous Thromboembolism Group of the Spanish Society of Internal Medicine and the Catalan Society of Contraception"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1061-0200","authenticated-orcid":false,"given":"A.","family":"Franco Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Perell\u00f3 Cap\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Madridano Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mu\u00f1oz Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mart\u00edn Asenjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Blanco Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2026.502579_bib0005","series-title":"World family planning 2022: meeting the changing needs for family planning: contraceptive use by age and method","year":"2022"},{"key":"10.1016\/j.rceng.2026.502579_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res."},{"key":"10.1016\/j.rceng.2026.502579_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u201309","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ."},{"issue":"6","key":"10.1016\/j.rceng.2026.502579_bib0020","first-page":"644","article-title":"Hormonal contraception and venous thromboembolism","volume":"91","author":"Lidegaard","year":"2012","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"1","key":"10.1016\/j.rceng.2026.502579_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism","volume":"107","year":"2017","journal-title":"Fertil Steril."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0030","article-title":"Combined oral contraceptives and venous thrombosis: a systematic review and meta-analysis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1016\/j.rceng.2026.502579_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"Douxfils","year":"2024","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"10.1016\/j.rceng.2026.502579_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate 2.5 mg and 17-\u03b2-oestradiol 1.5 mg (PRO-E2 study)","volume":"26","author":"Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception."},{"key":"10.1016\/j.rceng.2026.502579_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110727","article-title":"Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: a disproportionality analysis of the Eudravigilance database","volume":"142","author":"Didembourg","year":"2025","journal-title":"Contraception."},{"issue":"5","key":"10.1016\/j.rceng.2026.502579_bib0060","first-page":"339","article-title":"Venous thrombosis and hormonal contraception","volume":"23","author":"Fruzzetti","year":"2018","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"10.1016\/j.rceng.2026.502579_bib0065","article-title":"Progestin-only contraception and thrombosis: an updated systematic review","author":"Tepper","year":"2025","journal-title":"Contraception."},{"issue":"6","key":"10.1016\/j.rceng.2026.502579_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1024\/0301-1526\/a000726","article-title":"Sex hormones and venous thromboembolism \u2013 from contraception to hormone replacement therapy","volume":"47","author":"Beyer-Westendorf","year":"2018","journal-title":"Vasa."},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0075","first-page":"290","article-title":"Venous thromboembolism issues in women","volume":"42","author":"Linnemann","year":"2022","journal-title":"H\u00e4mostaseologie."},{"key":"10.1016\/j.rceng.2026.502579_bib0080","series-title":"Actualizaci\u00f3n en el manejo cl\u00ednico de la anticoncepci\u00f3n hormonal, intrauterina y de urgencia. Conferencia de Consenso","year":"2011"},{"key":"10.1016\/j.rceng.2026.502579_bib0085","series-title":"Medical eligibility criteria for contraceptive use","year":"2025"},{"key":"10.1016\/j.rceng.2026.502579_bib0090","series-title":"Combined hormonal contraception","year":"2019"},{"issue":"2","key":"10.1016\/j.rceng.2026.502579_bib0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/a-1259-1609","article-title":"Hormonal contraception. Guideline of the DGGG, OEGGG and SGGG (S3 level)","volume":"81","author":"Franik","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"6","key":"10.1016\/j.rceng.2026.502579_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost."},{"issue":"23","key":"10.1016\/j.rceng.2026.502579_bib0105","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.rceng.2026.502579_bib0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"van Vlijmen","year":"2016","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rceng.2026.502579_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: A British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100161","article-title":"Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias","volume":"7","author":"Baldwin","year":"2023","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.rceng.2026.502579_bib0130","series-title":"Combined hormonal contraceptives and venous thromboembolism: Article 31 referral\u2014Annex II","year":"2014"},{"key":"10.1016\/j.rceng.2026.502579_bib0135","series-title":"Venous thromboembolism in women on estrogen therapy: presentation, management, and outcomes in the RIETE Registry. Comunicaci\u00f3n oral presentada en: Belgian Society on Thrombosis and Haemostasis (BSTH) Annual Meeting","year":"2025"},{"issue":"18","key":"10.1016\/j.rceng.2026.502579_bib0140","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.jacc.2020.06.090","article-title":"Venous thromboembolism associated with pregnancy: JACC focus seminar","volume":"76","author":"Nichols","year":"2020","journal-title":"J Am Coll Cardiol."},{"issue":"11","key":"10.1016\/j.rceng.2026.502579_bib0145","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s11606-022-07528-y","article-title":"Special considerations for women of reproductive age on anticoagulation","volume":"37","author":"Azenkot","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.rceng.2026.502579_bib0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/hematology.2022000401","article-title":"Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation","volume":"2022","author":"DeLoughery","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"16","key":"10.1016\/j.rceng.2026.502579_bib0155","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"de Jong","year":"2022","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.rceng.2026.502579_bib0160","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan","year":"2024","journal-title":"J Thromb Haemost."},{"issue":"26","key":"10.1016\/j.rceng.2026.502579_bib0165","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med."},{"issue":"14","key":"10.1016\/j.rceng.2026.502579_bib0170","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med."},{"issue":"24","key":"10.1016\/j.rceng.2026.502579_bib0175","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1016\/j.rceng.2026.502579_bib0180","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.rceng.2026.502579_bib0185","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rceng.2026.502579_bib0190","article-title":"Safety of contraception among women using Anticoagulant therapy: an updated systematic review","author":"Nguyen","year":"2025","journal-title":"Contraception."},{"issue":"5","key":"10.1016\/j.rceng.2026.502579_bib0195","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.contraception.2011.06.008","article-title":"Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives","volume":"84","author":"Vaillant-Roussel","year":"2011","journal-title":"Contraception."},{"issue":"Suppl 1","key":"10.1016\/j.rceng.2026.502579_bib0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(19)30357-3","article-title":"Optimal management of hormonal contraceptives after an episode of venous thromboembolism","volume":"181","author":"Klok","year":"2019","journal-title":"Thromb Res."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.rceng.2026.502579_bib0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.rceng.2026.502579_bib0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"14","key":"10.1016\/j.rceng.2026.502579_bib0225","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2021.02.025","article-title":"Contraception and reproductive planning for women with cardiovascular disease: JACC Focus Seminar 5\/5","volume":"77","author":"Lindley","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.rceng.2026.502579_bib0230","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.rceng.2026.502579_bib0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bpobgyn.2019.09.003","article-title":"Contraception and preconception counseling in women with autoimmune disease","volume":"64","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"Contributors. U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.rceng.2026.502579_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.rceng.2026.502579_bib0255","article-title":"Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, and cervical cancer: Joint with the Society of Gynecologic Oncology","volume":"147","author":"Batur","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.rceng.2026.502579_bib0260","volume":"147","author":"Batur","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.rceng.2026.502579_bib0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13625187.2019.1602721","article-title":"Contraception in cancer survivors - an expert review Part I. Breast and gynaecological cancers","volume":"24","author":"Gompel","year":"2019","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"1","key":"10.1016\/j.rceng.2026.502579_bib0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"Gemzell-Danielsson","year":"2022","journal-title":"BJOG."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2021.05.002","article-title":"Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results","volume":"104","author":"Creinin","year":"2021","journal-title":"Contraception."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0280","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000005509","article-title":"Venous thromboembolic risk of estradiol valerate-dienogest compared with ethinyl estradiol-levonorgestrel combined oral contraceptives","volume":"143","author":"Bauerfeind","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rceng.2026.502579_bib0285","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ."},{"issue":"4","key":"10.1016\/j.rceng.2026.502579_bib0290","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol."},{"issue":"3","key":"10.1016\/j.rceng.2026.502579_bib0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception."},{"issue":"1","key":"10.1016\/j.rceng.2026.502579_bib0300","first-page":"46","article-title":"Hormones and thrombosis: the dark side of the moon","volume":"22","author":"Barcellona","year":"2024","journal-title":"Blood Transfus."}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:03:23Z","timestamp":1785701003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887426001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2254887426001116"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502579","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolic disease associated with hormonal contraceptives. Venous Thromboembolism Group of the Spanish Society of Internal Medicine and the Catalan Society of Contraception","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2026.502579","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502579"}}